RxDoctor Payments Data

Leah Spinner, MD

Critical Care Medicine · Mayfield Heights, OHNPI 1346374428

Payments from drug & device makers

$185in general payments, 2019–2025

Across 11 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$25
  • Insmed, Inc.$22
  • Mylan Specialty L.p.$19
  • Advanced Respiratory, Inc$18
  • GSK$17
  • Sanofi$16
  • plus $67 from 5 others

What the payments were for

  • Food & beverage$17394%
  • Education$126%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$185 in reported general payments places this provider in the 35th percentile of 285 critical care medicine providers in Ohio.

See all critical care medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$68,100
Medicare patients
584
Services billed
950

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter401$303,912
Breo ElliptaFluticasone/Vilanterol239$123,151
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr177$110,421
Spiriva RespimatTiotropium Bromide124$80,652
Incruse ElliptaUmeclidinium Bromide101$42,573
Breztri AerosphereBudesonide/Glycopyr/Formoterol58$41,806
Spiriva HandihalerTiotropium Bromide29$25,046
SymbicortBudesonide/Formoterol Fumarate70$24,837
Stiolto RespimatTiotropium Br/Olodaterol Hcl49$24,514
DuleraMometasone/Formoterol61$24,443
Arnuity ElliptaFluticasone Furoate53$20,022
Fluticasone-SalmeterolFluticasone Propion/Salmeterol118$12,824
Advair HfaFluticasone Propion/Salmeterol20$12,752
Albuterol Sulfate HfaAlbuterol Sulfate482$12,142
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate115$11,800

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta$17$600,079971 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat$15$105,166173 claims
AstraZenecaBreztri Aerosphere, Symbicort$12$66,643128 claims
MerckDulera, Asmanex$13$26,10072 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 285 critical care medicine providers in Ohio.

Other critical care medicine in Mayfield Heights

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →